Question 1

Has Roy Peters, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $201,457 in general payments to Roy Peters, MD across 63 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Roy Peters, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Roy Peters, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
F. Hoffmann-la Roche AG	17	$70,206
Currax Pharmaceuticals LLC	16	$58,196
Genentech, Inc.	18	$54,297
Ardelyx, Inc.	1	$9,400
Teva Pharmaceuticals USA, Inc.	11	$9,357

Drug	Claims	Cost to plans & patients
EliquisApixaban	11	$10,748
Potassium Chloride	23	$315
Metoprolol Succinate	15	$232
Losartan Potassium	14	$228
Diltiazem 24hr Er (Cd)Diltiazem Hcl	12	$169
Metoprolol Tartrate	28	$155
CefuroximeCefuroxime Axetil	21	$145
Furosemide	36	$133
Torsemide	14	$115
Amlodipine Besylate	17	$61
Prednisone	18	$59
Hydralazine Hcl	13	$47
Lisinopril	11	$27

Roy Peters, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Most prescribed under Part D

Other internal medicine in High Point